364 related articles for article (PubMed ID: 18336315)
1. Cancer-associated carbonic anhydrases and their inhibition.
Pastorekova S; Zatovicova M; Pastorek J
Curr Pharm Des; 2008; 14(7):685-98. PubMed ID: 18336315
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
Supuran CT
Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
4. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
Guler OO; De Simone G; Supuran CT
Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
Pastorek J; Pastorekova S
Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
Supuran CT; Winum JY
Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
[TBL] [Abstract][Full Text] [Related]
7. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
[TBL] [Abstract][Full Text] [Related]
8. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
Ozensoy Guler O; Arslan O; Kockar F
Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of carbonic anhydrase IX: a new strategy against cancer.
Winum JY; Scozzafava A; Montero JL; Supuran CT
Anticancer Agents Med Chem; 2009 Jul; 9(6):693-702. PubMed ID: 19601749
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
[TBL] [Abstract][Full Text] [Related]
11. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
[TBL] [Abstract][Full Text] [Related]
12. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
Carradori S
Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
Nocentini A; Supuran CT
Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain.
Zatovicova M; Jelenska L; Hulikova A; Csaderova L; Ditte Z; Ditte P; Goliasova T; Pastorek J; Pastorekova S
Curr Pharm Des; 2010; 16(29):3255-63. PubMed ID: 20819068
[TBL] [Abstract][Full Text] [Related]
17. [Progress in the study of carbonic anhydrase inhibitors as potential anticancer drugs].
Guo J; Li FR; Liu Y; Cheng MS
Yao Xue Xue Bao; 2013 Nov; 48(11):1637-43. PubMed ID: 24475699
[TBL] [Abstract][Full Text] [Related]
18. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors and the management of cancer.
Pastorekova S; Kopacek J; Pastorek J
Curr Top Med Chem; 2007; 7(9):865-78. PubMed ID: 17504131
[TBL] [Abstract][Full Text] [Related]
20. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
Monti SM; Supuran CT; De Simone G
Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
